HomeAPS • TSE
add
Aptose Biosciences Inc
Previous close
$2.39
Day range
$2.35 - $2.38
Year range
$1.02 - $5.80
Market cap
38.66M CAD
Avg Volume
5.72K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.43M | 239.64% |
Net income | -7.76M | -389.53% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.42M | -240.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 935.00K | -84.80% |
Total assets | 10.01M | -1.14% |
Total liabilities | 37.18M | 153.44% |
Total equity | -27.17M | — |
Shares outstanding | 2.55M | — |
Price to book | -0.22 | — |
Return on assets | -227.11% | — |
Return on capital | 9,547.56% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -7.76M | -389.53% |
Cash from operations | -5.84M | 27.53% |
Cash from investing | — | — |
Cash from financing | 8.30M | 21.97% |
Net change in cash | 2.46M | 295.94% |
Free cash flow | -5.65M | 27.24% |
About
Founded
1986
Headquarters
Website
Employees
13
